Showing 41-50 of 118 results for "".
A Non-Invasive 2-Gene Molecular Assay Shows Promise in Assessment of Pigmented Lesions
https://practicaldermatology.com/topics/skin-cancer-photoprotection/a-non-invasive-2-gene-molecular-assay-shows-promise-in-assessment-of-pigmented-lesions/20705/More studies are needed, but a non-invasive assay that identified melanoma gene expression could support clinical decision making.Melanoma Mortality: Women Maintain the Advantage
https://practicaldermatology.com/topics/skin-cancer-photoprotection/melanoma-mortality-women-maintain-the-advantage/20387/Global data show that men have higher rates of mortality and more rapid melanoma progression. We still don't know why.The Road Ahead in Skin Cancer Research and Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/the-road-ahead-in-skin-cancer-research-and-treatment/21459/Total Body Skin Exams: Don't Abandon Them
https://practicaldermatology.com/topics/skin-cancer-photoprotection/total-body-skin-exams-dont-abandon-them/20628/Lesion-directed exams may save time, but is the limited temporal savings worth it?Who Needs UV Education and Who Should Provide It?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/who-needs-uv-education-and-who-should-provide-it/20509/New recommendations from the United States Preventive Services Task Force seem to limit the PCP's role in patient UV education.Pregnancy and Melanoma: What We Know About the Risks
https://practicaldermatology.com/topics/practice-management/pregnancy-and-melanoma-what-we-know-about-the-risks/21041/Against a backdrop of conflicting findings, a new study suggests a significant risk associated with melanoma during pregnancy.Jonathan Weiss, MD, Talks Acne Products with Benzoyl Peroxide (BPO) and How He's Advising Patients after Valisure's FDA Citizen's Petition
https://practicaldermatology.com/topics/acne-rosacea/jonathan-weiss-md-talks-acne-products-benzoyl-peroxide-bpo-and-how-hes-advising-patients-after-valisures-fda-citizens-petition/24170/Jonathan Weiss, MD, a dermatologist from Atlanta, says that at this point, "we just don’t know enough." He said he still feels comfortable prescribing these acne products with benzoyl peroxide (BPO) at the present time, and that more information is needed. His advice to fellow dermatologists is to uSignificant FDA Approval for PDT
https://practicaldermatology.com/series/pdt-in-practice/significant-fda-approval-pdt/29102/Dr. Jonathan S. Weiss discusses the importance of a recent FDA approval involving dosing of a PDT photosensitizer for both lesion-directed and field-directed treatment of actinic keratosis.“You Say Goodbye, and I Say…”
https://practicaldermatology.com/series/editors-message/you-say-goodbye-and-i-say/23889/Is a Good Faith Estimate Required for a Filler or Neuromodulator Treatment?
https://practicaldermatology.com/topics/practice-management/is-a-good-faith-estimate-required-for-a-filler-or-neuromodulator-treatment/23852/The latest updates from CMS do not specifically mention aesthetics in reference to good faith estimates, but there are indications that some aesthetic and dermatology services will require them. What about an appointment for injectables?